2024-517601-82-00RecruitingPhase 1/2
MB-CART2019.1 in refractory MS
Source: EU CTIS (euclinicaltrials.eu) · Last updated 18 Sept 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- First submitted
- 28 Mar 2025
- Start date
- 1 Apr 2026
- Lead sponsor
- Miltenyi Biomedicine GmbH
- Diseases
- Multiple sclerosis
- EU CT number
- 2024-517601-82-00
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 25
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Charite Universitaetsmedizin Berlin KöR | Berlin | Germany | Recruiting |
| University Medical Center Hamburg-Eppendorf | Hamburg | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.